Ambrisentan structure
Ambrisentan
White to Off White SolidAmbrisentan is a selective endothelin-A (ETA) receptor antagonist introduced for the oral treatment of patients with pulmonary arterial
hypertension (PAH), to improve exercise capacity and delay clinical worsening.
It is the third ET-receptor antagonist to be marketed for this indication behind
bosentan and sitaxsentan. PAH is a rare disease of the small pulmonary arteries
characterized by vascular proliferation and remodeling, resulting in a
progressive increase in
Find 15 Related Holders
JIANGSU JOYGLORY PHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Active
TIANJIN WEIJIE PHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Active
Sun Pharmaceutical Industries Ltd
United States
United States
API Registration Country
API Active
WATSON PHARMA PRIVATE LTD
United States
United States
API Registration Country
API Inactive
-
Country:
United States -
Email:
Jiangsu Sinobiopharma Co., Ltd.
China
China
API Registration Country
API Inactive
-
Founded in:
2013-10-09 -
Country:
China -
Address:
No. 29, Tongwang Road, Nantong Economic and Technological Development Zone, Jiangsu Province -
Tax NO.:
91320691076338999D -
Registered Funds:
187.72934737 yuan -
Website:
-
Email:
Recommended Suppliers of Ambrisentan
-
Greenbo Biochem
CN1 YR
Contact Supplier -
ROYAL PHARM
CN1 YR
Contact Supplier -
Henan Lihao Chem Plant Limited
CN1 YR
Contact Supplier -
Hainan Flying International Trade Co., L
CN1 YR
Contact Supplier -
Shanghai Lonwin Chemical Co.,Ltd
CN1 YR
Contact Supplier